½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1429612

¼¼°èÀÇ ÇÁ·ÎÅ׿À¹Í½º ½ÃÀå º¸°í¼­(2024³â)

Proteomics Global Market Report 2024

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 175 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

ÇÁ·ÎÅ׿À¹Í½º ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³âµ¿¾È ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 2028³â¿¡´Â 13.6%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î 586¾ï 1,000¸¸ ´Þ·¯ ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ¼ºÀå¼¼´Â ÇÁ·ÎÅ׿À¹Í½º À̴ϼÅƼºê¿¡ ´ëÇÑ ÀÚ±ÝÀÇ ±ÞÁõ, °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¿¬±¸°³¹ß È°µ¿ Áõ°¡, Äڷγª19 °¨¿° »çÅ·ΠÀÎÇØ ÃËÁøµÈ »ý¸í°øÇÐ ±â¾÷¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡¿Í °ü·ÃÀÌ ÀÖÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¼Ò·®ÀÇ »ùÇÃÀ» ½Äº°Çϱâ À§ÇÑ ³ª³ë ±â¼ú È°¿ë, Áö¼ÓÀûÀÎ ½Å±â¼ú °³¹ß, ½ÅÁ¦Ç° Ãâ½Ã, ÀΰøÁö´É(AI) ¹× ½Ç½Ã°£°ú °°Àº ±â¼ú¿¡ ´ëÇÑ Àü·«Àû ÅõÀÚ¿¡ ´ëÇÑ ÁýÁßÀûÀÎ ³ë·Â µîÀÌ ÀÖ½À´Ï´Ù.

ÇÁ·ÎÅ׿À¹Í½º ½ÃÀåÀÇ ¹ßÀüÀº ÇÁ·ÎÅ׿À¹Í½º ¿¬±¸¿¡ ´ëÇÑ Á¤ºÎ ÀÚ±Ý ¹èºÐÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. Á¤ºÎ ÀÚ±Ý Áö¿øÀº ½Å¾à °³¹ß, Áúº´ Áø´Ü ¹× Ä¡·á¿¡ Á¾»çÇÏ´Â ¿¬±¸Àڵ鿡°Ô Áß¿äÇÑ Áö¿ø ¿ªÇÒÀ» ÇÕ´Ï´Ù. ÁÁÀº ¿¹·Î È£ÁÖ¿¡ º»»ç¸¦ µÐ ÀÇ·á ±â¼ú ȸ»ç ÀÎ Proteomics International Laboratories Limited´Â 2022³â 5¿ùÈ£ÁÖ¿¡¼­ Á¦Á¶ ´É·ÂÀ» °­È­Çϱâ À§ÇØ 40¸¸ ´Þ·¯ÀÇ ÀÚ±ÝÀ» È®º¸Çß½À´Ï´Ù. ÀÌ ÀçÁ¤Àû Áö¿øÀº Proteomics International Laboratories LimitedÀÇ Àü¹® ISO 13485 ÀÎÁõ È®´ë¸¦ Æ÷ÇÔÇÏ¿© È£ÁÖ ¹× µ¿³²¾Æ½Ã¾Æ¿¡¼­ PromarkD Å×½ºÆ®ÀÇ »ý»ê ÃËÁøÀ» ÃËÁøÇÏ´Â °ÍÀ» ¸ñÇ¥·ÎÇÕ´Ï´Ù. µû¶ó¼­ Á¤ºÎ ÀÚ±Ý Áõ°¡´Â ÇÁ·ÎÅ׿À¹Í½º ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¥ °ÍÀÔ´Ï´Ù.

È®´ëµÇ´Â Á¦¾à »ê¾÷Àº ÇâÈÄ ÇÁ·ÎÅ׿À¹Í½º ½ÃÀåÀÇ ¼ºÀåÀ» °ßÀÎÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀǾàÇ°ÀÇ ¿¬±¸, °³¹ß, Á¦Á¶ ¹× À¯ÅëÀ» Àü¹®À¸·Î ÇÏ´Â Á¦¾à ºÎ¹®Àº ÀǾàÇ° °³¹ß¿¡ ÀÖ¾î ÇÁ·ÎÅ׿À¹Í½º¿¡ Å©°Ô ÀÇÁ¸ÇÏ°í ÀÖ½À´Ï´Ù. ÇÁ·ÎÅ׿À¹Í½º´Â ½Å¾à°³¹ß Ç¥Àû ¹× ¹ÙÀÌ¿À¸¶Ä¿ ¹ß±¼À» À§ÇÑ ´Ü¹éÁúÀÇ ½Äº°, Ư¼ºÈ­ ¹× ¸ð´ÏÅ͸µ¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, º§±â¿¡¿¡ º»»ç¸¦ µÐ ¾÷°è ´ÜüÀÎ EFPIA(European Federation of Pharmaceutical Industries and Associations)¿¡ µû¸£¸é, 2023³â 6¿ù À¯·´ ÀǾàÇ° »ý»ê¾×Àº 2022³â 4,002¾ï ´Þ·¯(3,400¾ï À¯·Î)¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇß½À´Ï´Ù. 400¾ï À¯·Î)¿¡ µµ´ÞÇÏ¿© 3,816¾ï 4,100¸¸ ´Þ·¯¿¡¼­ Áõ°¡ÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. µû¶ó¼­ ±Þ¼ºÀåÇÏ´Â Á¦¾à »ê¾÷Àº ÇÁ·ÎÅ׿À¹Í½º ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Ư¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

  • °íÀÎÇ÷¹À̼ÇÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • ¿ìÅ©¶óÀ̳ª¡¤·¯½Ã¾Æ ÀüÀïÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦5Àå ¼¼°è ½ÃÀå ±Ô¸ð¿Í ¼ºÀå

  • ¼¼°èÀÇ ÇÁ·ÎÅ׿À¹Í½º ½ÃÀå ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ¼¼°èÀÇ ÇÁ·ÎÅ׿À¹Í½º ½ÃÀå ±Ô¸ð ½ÇÀû°ú ¼ºÀå, 2018-2023³â
  • ¼¼°èÀÇ ÇÁ·ÎÅ׿À¹Í½º ½ÃÀå ±Ô¸ð¿Í ¼ºÀå ¿¹Ãø, 2023-2028³â, 2033³â

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ ÇÁ·ÎÅ׿À¹Í½º ½ÃÀå, ÄÄÆ÷³ÍÆ®º° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2018-2023³â, 2023-2028³â, 2033³â
  • ½Ã¾à
  • ±â±â
  • ¼¼°èÀÇ ÇÁ·ÎÅ׿À¹Í½º ½ÃÀå, ±â±âº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2018-2023³â, 2023-2028³â, 2033³â
  • ´Ü¹éÁú ¸¶ÀÌÅ©·Î¾î·¹ÀÌ
  • ºÐ±¤¹ý
  • X¼± °áÁ¤ ±¸Á¶ ºÐ¼®
  • Å©·Î¸¶Åä±×·¡ÇÇ
  • Àü±â¿µµ¿
  • Ç¥¸é ÇöóÁî¸ó °ø¸í
  • ´Ü¹éÁú ºÐ¸®
  • ¼¼°èÀÇ ÇÁ·ÎÅ׿À¹Í½º ½ÃÀå, ¼­ºñ½º¿Í ¼ÒÇÁÆ®¿þ¾îº° ¼¼ºÐÈ­, ½ÇÀû°ú ¿¹Ãø, 2018-2023³â, 2023-2028³â, 2033³â
  • ÄÚ¾î ÇÁ·ÎÅ׿À¹Í½º ¼­ºñ½º
  • ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º ¼ÒÇÁÆ®¿þ¾î ¹× ¼­ºñ½º

Á¦7Àå Áö¿ª ¹× ±¹°¡º° ºÐ¼®

  • ¼¼°èÀÇ ÇÁ·ÎÅ׿À¹Í½º ½ÃÀå, Áö¿ªº°, ½ÇÀû°ú ¿¹Ãø, 2018-2023³â, 2023-2028³â, 2033³â
  • ¼¼°èÀÇ ÇÁ·ÎÅ׿À¹Í½º ½ÃÀå, ±¹°¡º°, ½ÇÀû°ú ¿¹Ãø, 2018-2023³â, 2023-2028³â, 2033³â

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

  • ÇÁ·ÎÅ׿À¹Í½º ½ÃÀå °æÀï ±¸µµ
  • ÇÁ·ÎÅ׿À¹Í½º ½ÃÀå ±â¾÷ °³¿ä
    • Danaher Corporation
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Agilent Technologies Inc.
    • PerkinElmer Inc.

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½Å ±â¾÷

  • Bruker Corporation
  • Bio-Rad Laboratories Inc.
  • Promega Corporation
  • Waters Corporation
  • Creative Proteomics
  • Sino Biological
  • EIAab
  • DIMA Biotechnology
  • TechnoConcept India Pvt. Ltd.
  • Cellular &Molecular Biology
  • GE Healthcare
  • Perseus Proteomics Inc.
  • JEOL
  • APTBIO
  • Leisure Science(Suzhou) Co. Ltd.

Á¦32Àå °æÀï º¥Ä¡¸¶Å·

Á¦33Àå °æÀï ´ë½Ãº¸µå

Á¦34Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦35Àå ÇâÈÄ Àü¸Á°ú ÀáÀ缺 ºÐ¼®

Á¦36Àå ºÎ·Ï

LSH 24.03.08

Proteomics involves the examination of the structure and functions of proteins, playing a crucial role in drug discovery, disease diagnosis, and treatment. It is employed to assess the production rate of proteins, the participation of proteins in metabolic pathways, and the modifications undergone by proteins.

The primary categories of proteomics include protein microarrays, spectroscopy, X-ray crystallography, chromatography, electrophoresis, surface plasmon resonance, and protein fractionation. The essential elements utilized in proteomics encompass reagents, instruments, and software, all contributing to proteomic analytical services and instrument services.

The proteomics market research report is one of a series of new reports from The Business Research Company that provides proteomics market statistics, including proteomics industry global market size, regional shares, competitors with a proteomics market share, detailed proteomics market segments, market trends, and opportunities, and any further data you may need to thrive in the proteomics industry. This proteomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The proteomics market size has grown rapidly in recent years. It will grow from $30.84 billion in 2023 to $35.21 billion in 2024 at a compound annual growth rate (CAGR) of 14.2%. The expansion observed in the historical period can be ascribed to the escalation in government funding for proteomics research, technological advancements, an upswing in healthcare expenditure, an increase in the number of healthcare facilities, and economic growth in emerging markets.

The proteomics market size is expected to see rapid growth in the next few years. It will grow to $58.61 billion in 2028 at a compound annual growth rate (CAGR) of 13.6%. The anticipated expansion in the forecast period can be linked to the surge in funding for proteomics initiatives, a growing demand for personalized medicine, increased research and development activities, and heightened investments in biotech companies spurred by the COVID-19 outbreak. Key trends expected in the forecast period involve a concentrated effort on utilizing nanotechnology to identify low-abundant samples, the continual development of new technologies, the introduction of novel products, and strategic investments in technologies such as artificial intelligence (AI) and real-time enhanced imaging.

The advancement of the proteomics market is propelled by the increasing allocation of government funds towards proteomics research. Government funding serves as a crucial support for researchers engaged in drug discovery, disease diagnosis, and treatment. A case in point is Proteomics International Laboratories Limited, an Australia-based medical technology company, which, in May 2022, secured $400,000 in funding to enhance its manufacturing capabilities in Australia. This financial support aims to facilitate the production advancement of the PromarkerD test in Australia and South-East Asia, involving the expansion of Proteomics International's specialized ISO 13485 certification. Consequently, the rise in government funds has a positive impact on the proteomics market.

The expanding pharmaceutical industry is anticipated to drive the future growth of the proteomics market. The pharmaceutical sector, dedicated to the research, development, manufacturing, and distribution of drugs and medications, heavily relies on proteomics for drug development. Proteomics plays a vital role in identifying, characterizing, and monitoring proteins for drug targets and biomarker discovery. For example, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association, in June 2023, the total pharmaceutical production in Europe reached $400,200 million (€340,000 million) in 2022, indicating an increase from $381,641 million (€323,950 million) in 2021. Hence, the burgeoning pharmaceutical industry acts as a driving force for the growth of the proteomics market.

Companies are introducing new products to augment their revenue streams and gain a competitive advantage over their rivals. As an illustration, in June 2021, Bruker Corporation, a US-based manufacturer of scientific instruments, unveiled two new trapped ion mobility spectrometry time-of-flight (timsTOF) instruments during its 4D-Proteomics eXceed Symposium. These devices, founded on ion mobility separation and mass spectrometry, are poised to bring about advancements in proteomics, epiproteomics/PTM characterization, and deep multiomic biomarker discovery.

Key players in the proteomics market are strategically focusing on the development of precise quantitative analysis kits to enhance their competitive position. These kits are instrumental in accurately measuring protein expression levels and identifying biomarkers across various biological samples. For instance, in January 2023, SCIEX, a US-based manufacturer of mass spectrometry instrumentation, launched the Fast Glycan Labeling and Analysis kit and an update for the Biologics Explorer software. This kit is specifically designed for precise quantitative glycan analysis, while the software update aims to enhance key workflows for the analysis of protein therapeutics. These solutions accelerate the examination and identification of glycans associated with proteins, providing researchers with advanced resources for comprehensive biopharmaceutical analysis. The software empowers researchers to make informed decisions regarding the most suitable analytical methods and tools for their specific applications, ultimately improving the efficiency and effectiveness of protein characterization studies.

In August 2021, Danaher Corporation, a US-based provider of medical, industrial, and commercial products and services, acquired Aldevron LLC for an undisclosed amount. This acquisition is geared towards expanding Danaher Corporation's capabilities in the genomic medicine field and supporting its customers in accelerating the development of life-saving therapies and vaccines for the market. Aldevron LLC, the acquired company, is a US-based biotechnology firm specializing in proteomics.

Major companies operating in the proteomics market report are Danaher Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Bruker Corporation, Bio-Rad Laboratories Inc., Promega Corporation, Waters Corporation, Creative Proteomics, Sino Biological, EIAab, DIMA Biotechnology, TechnoConcept India Pvt. Ltd., Cellular & Molecular Biology, GE Healthcare, Perseus Proteomics Inc., JEOL, APTBIO, Leisure Science (Suzhou) Co. Ltd., Centre for Cellular & Molecular Biology, Vproteomics, Shimadzu Corporation, Abcam PLC, IRB Barcelona, SGS UK, MRM Proteomics Inc., FingerPrints, Biognosys AG, Olink Proteomics, Horiba, MS Bioworks, LC Sciences, MtoZ Biolabs, Integrated Proteomics Applications, Quantumbio Inc., Luminex Corporation, Applied Biomics Inc., Isoplexis Corporation, Caprion Proteomics Inc.

North America was the largest region in the proteomics market in 2023. Western Europe was the second largest region in the global proteomics market share. The regions covered in the proteomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the proteomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The proteomics market consists of sales of proteins that are used for drug discovery, clinical diagnosis, molecular medicine and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Proteomics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on proteomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for proteomics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The proteomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Component: Reagents; Instruments; Software
  • 2) By Instrument: Protein Microarrays; Spectroscopy; X-ray Crystallography; Chromatography; Electrophoresis; Surface Plasmon Resonance; Protein Fractionation
  • 3) By Type: Core Instrument Services; Proteomic Analytical Services
  • Companies Mentioned: Danaher Corporation; Thermo Fisher Scientific Inc.; Merck KGaA; Agilent Technologies Inc.; PerkinElmer Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Proteomics Market Characteristics

3. Proteomics Market Trends And Strategies

4. Proteomics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Proteomics Market Size and Growth

  • 5.1. Global Proteomics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Proteomics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Proteomics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Proteomics Market Segmentation

  • 6.1. Global Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Reagents
  • Instruments
  • 6.2. Global Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Protein Microarrays
  • Spectroscopy
  • X-ray Crystallography
  • Chromatography
  • Electrophoresis
  • Surface Plasmon Resonance
  • Protein Fractionation
  • 6.3. Global Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Core Proteomics Services
  • Bioinformatics Software & Services

7. Proteomics Market Regional And Country Analysis

  • 7.1. Global Proteomics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Proteomics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Proteomics Market

  • 8.1. Asia-Pacific Proteomics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Proteomics Market

  • 9.1. China Proteomics Market Overview
  • 9.2. China Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Proteomics Market

  • 10.1. India Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Proteomics Market

  • 11.1. Japan Proteomics Market Overview
  • 11.2. Japan Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Proteomics Market

  • 12.1. Australia Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Proteomics Market

  • 13.1. Indonesia Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Proteomics Market

  • 14.1. South Korea Proteomics Market Overview
  • 14.2. South Korea Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Proteomics Market

  • 15.1. Western Europe Proteomics Market Overview
  • 15.2. Western Europe Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Proteomics Market

  • 16.1. UK Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Proteomics Market

  • 17.1. Germany Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Proteomics Market

  • 18.1. France Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Proteomics Market

  • 19.1. Italy Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Proteomics Market

  • 20.1. Spain Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Proteomics Market

  • 21.1. Eastern Europe Proteomics Market Overview
  • 21.2. Eastern Europe Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Proteomics Market

  • 22.1. Russia Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Proteomics Market

  • 23.1. North America Proteomics Market Overview
  • 23.2. North America Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Proteomics Market

  • 24.1. USA Proteomics Market Overview
  • 24.2. USA Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Proteomics Market

  • 25.1. Canada Proteomics Market Overview
  • 25.2. Canada Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Proteomics Market

  • 26.1. South America Proteomics Market Overview
  • 26.2. South America Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Proteomics Market

  • 27.1. Brazil Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Proteomics Market

  • 28.1. Middle East Proteomics Market Overview
  • 28.2. Middle East Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Proteomics Market

  • 29.1. Africa Proteomics Market Overview
  • 29.2. Africa Proteomics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Proteomics Market, Segmentation By Instrument, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Proteomics Market, Segmentation By Service and Software, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Proteomics Market Competitive Landscape And Company Profiles

  • 30.1. Proteomics Market Competitive Landscape
  • 30.2. Proteomics Market Company Profiles
    • 30.2.1. Danaher Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Thermo Fisher Scientific Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Agilent Technologies Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. PerkinElmer Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Proteomics Market Other Major And Innovative Companies

  • 31.1. Bruker Corporation
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Promega Corporation
  • 31.4. Waters Corporation
  • 31.5. Creative Proteomics
  • 31.6. Sino Biological
  • 31.7. EIAab
  • 31.8. DIMA Biotechnology
  • 31.9. TechnoConcept India Pvt. Ltd.
  • 31.10. Cellular & Molecular Biology
  • 31.11. GE Healthcare
  • 31.12. Perseus Proteomics Inc.
  • 31.13. JEOL
  • 31.14. APTBIO
  • 31.15. Leisure Science (Suzhou) Co. Ltd.

32. Global Proteomics Market Competitive Benchmarking

33. Global Proteomics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Proteomics Market

35. Proteomics Market Future Outlook and Potential Analysis

  • 35.1 Proteomics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Proteomics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Proteomics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦